STRYKER CORP Deferred Income Tax Expense (Benefit)
STRYKER CORP (SYK) reported Deferred Income Tax Expense (Benefit) of $74.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-31
- STRYKER CORP deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $107.00M, a 33.95% decline year-over-year.
- STRYKER CORP deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$33.00M, a 335.71% decline year-over-year.
- STRYKER CORP deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $201.00M.
- STRYKER CORP deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $15.00M, a 50.00% increase year-over-year.
- STRYKER CORP deferred income tax expense (benefit) for fiscal 2025 was $392.00M.
- STRYKER CORP deferred income tax expense (benefit) for fiscal 2024 was -$370.00M.
- STRYKER CORP deferred income tax expense (benefit) for fiscal 2023 was -$206.00M, a 455.17% decline from fiscal 2022.
- STRYKER CORP deferred income tax expense (benefit) for fiscal 2022 was $58.00M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $107.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $74.00M 10-Q · filed 2026-07-31 | $275.00M derived: sum of 3 quarters · filed 2026-07-31 | $290.00M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2026-03-31 | -$33.00M 10-Q · filed 2026-05-11 | $168.00M derived: sum of 2 quarters · filed 2026-05-11 | $183.00M derived: sum of 3 quarters · filed 2026-05-11 | $345.00M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-12-31 | $201.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $216.00M derived: sum of 2 quarters · filed 2026-02-11 | $378.00M derived: sum of 3 quarters · filed 2026-07-31 | $392.00M 10-K · filed 2026-02-11 | |
| 2025-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $177.00M derived: sum of 2 quarters · filed 2026-07-31 | $191.00M 10-Q · filed 2025-10-31 | -$158.00M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-06-30 | $162.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $176.00M 10-Q · filed 2026-07-31 | -$173.00M derived: sum of 3 quarters · filed 2026-07-31 | -$163.00M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-03-31 | $14.00M 10-Q · filed 2026-05-11 | -$335.00M derived: sum of 2 quarters · filed 2026-05-11 | -$325.00M derived: sum of 3 quarters · filed 2026-05-11 | -$317.00M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$349.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$339.00M derived: sum of 2 quarters · filed 2026-02-11 | -$331.00M derived: sum of 3 quarters · filed 2026-02-11 | -$370.00M 10-K · filed 2026-02-11 | |
| 2024-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $18.00M derived: sum of 2 quarters · filed 2025-10-31 | -$21.00M 10-Q · filed 2025-10-31 | -$223.00M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$31.00M 10-Q · filed 2025-08-01 | -$233.00M derived: sum of 3 quarters · filed 2026-02-11 | -$239.00M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-03-31 | -$39.00M 10-Q · filed 2025-05-02 | -$241.00M derived: sum of 2 quarters · filed 2026-02-11 | -$247.00M derived: sum of 3 quarters · filed 2026-02-11 | -$242.00M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2023-12-31 | -$202.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$208.00M derived: sum of 2 quarters · filed 2026-02-11 | -$203.00M derived: sum of 3 quarters · filed 2026-02-11 | -$206.00M 10-K · filed 2026-02-11 | |
| 2023-09-30 | -$6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$1.00M derived: sum of 2 quarters · filed 2024-10-30 | -$4.00M 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $2.00M 10-Q · filed 2024-07-31 | |||
| 2023-03-31 | -$3.00M 10-Q · filed 2024-05-01 | ||||
| 2022-12-31 | $58.00M 10-K · filed 2025-02-12 | ||||
| 2021-12-31 | -$237.00M 10-K · filed 2024-02-14 | ||||
| 2020-12-31 | $48.00M 10-K · filed 2023-02-10 | ||||
| 2019-12-31 | $126.00M 10-K · filed 2022-02-11 | ||||
| 2018-12-31 | -$1.58B 10-K · filed 2021-02-11 | ||||
| 2017-12-31 | $36.00M 10-K · filed 2020-02-06 | ||||
| 2016-12-31 | -$46.00M 10-K · filed 2019-02-07 | ||||
| 2015-12-31 | $87.00M 10-K · filed 2018-02-08 | ||||
| 2014-12-31 | $60.00M 10-K · filed 2017-02-09 | ||||
| 2013-12-31 | $23.00M 10-K · filed 2016-02-11 | ||||
| 2012-12-31 | -$39.00M 10-K · filed 2015-02-12 | ||||
| 2011-12-31 | -$164.00M 10-K · filed 2014-02-13 | ||||
| 2010-12-31 | -$104.00M 10-K · filed 2013-02-27 | -$103.80M 10-K · filed 2011-02-18 | |||
| 2009-12-31 | -$72.00M 10-K · filed 2012-02-13 | -$72.70M 10-K · filed 2011-02-18 | |||
| 2008-12-31 | -$17.60M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |